Upadoz 45mg Tablet (Upadacitinib)

Medicine OverView

Product Code:
260111
Country of Origin :
India
Dosage Form :
Tablet
Indication :
rheumatoid arthritis, psoriatic arthritis and autoimmune disease treatment, ulcerative colitis
Packaging :
28 tablets in bottle
Active Ingredient :
Upadacitinib
Manufacturer :
MSN Laboratories
Select your dosage
Product of India
Manufactured by:
MSN Laboratories

Free Delivery On $199 Or Above Of Cart Value
Select a Quantity
  • $184.00 ($6.57 per Tablet)
  • $330.00 ($5.89 per Tablet)
  • $445.00 ($15.89 per Tablet)
More Options Below

ALTERNATIVE MEDICINE


Description

Buy Upadacitinib 45mg Tablet Online – Advanced Rheumatoid Arthritis & Immune Therapy

Upadacitinib 45mg Tablet – Advanced JAK Inhibitor for Autoimmune Diseases

Rheumatoid Arthritis • Psoriatic Arthritis • Atopic Dermatitis • Targeted Immunotherapy

Upadacitinib 45mg Tablet is a prescription medicine belonging to the class of Janus Kinase (JAK) inhibitors. It is used in the treatment of various autoimmune and inflammatory conditions where the immune system becomes overactive and attacks healthy tissues.

It works by selectively inhibiting JAK1 enzymes, reducing inflammation, pain, swelling, and tissue damage in chronic autoimmune diseases. This targeted mechanism helps improve symptoms while slowing disease progression.

It is commonly prescribed in patients who do not respond adequately to traditional disease-modifying antirheumatic drugs (DMARDs).

Upadacitinib 45mg Tablet is used for the management of several chronic autoimmune conditions, including:

  • Rheumatoid Arthritis (RA)
  • Psoriatic Arthritis (PsA)
  • Ankylosing Spondylitis (AS)
  • Atopic Dermatitis (Eczema)
  • Ulcerative Colitis (in selected cases)

It helps reduce joint damage, skin inflammation, itching, stiffness, and long-term disability caused by autoimmune disease activity.

Upadacitinib works by blocking the activity of Janus Kinase 1 (JAK1), an enzyme involved in the inflammatory signaling pathway.

By inhibiting JAK1, it reduces the release of inflammatory cytokines responsible for pain, swelling, and immune system overactivity.

  • Reduces joint inflammation
  • Decreases immune overreaction
  • Improves skin and joint symptoms
  • Slows disease progression

The dosage of Upadacitinib 45mg Tablet is strictly determined by the doctor based on disease severity and patient response.

  • Usually taken once daily
  • Can be taken with or without food
  • Swallow whole with water
  • Do not crush or chew

Important: Regular monitoring is required during long-term therapy.

  • Upper respiratory tract infections
  • Headache
  • Nausea
  • Acne or skin rash
  • Increased liver enzymes
  • Fatigue

Serious side effects are rare but may include infections due to immune suppression.

  • Increases risk of infections
  • Avoid live vaccines during treatment
  • Use caution in liver or kidney disease
  • Not recommended during pregnancy unless advised
  • Regular blood monitoring required

Upadacitinib may interact with:

  • Strong immunosuppressants
  • Biologic DMARDs
  • Antifungal medicines (CYP inhibitors)
  • Antibiotics affecting liver enzymes
  • Targeted JAK1 inhibition therapy
  • Reduces joint pain and swelling
  • Improves skin inflammation in eczema
  • Helps improve mobility and quality of life
  • Works when traditional DMARDs fail
  • Store below 25°C
  • Keep in original packaging
  • Avoid moisture and direct sunlight
  • Keep out of reach of children

Upadacitinib 45mg Tablet is an advanced targeted therapy used for chronic autoimmune diseases. It helps control inflammation, reduce symptoms, and improve daily functioning in patients with moderate to severe conditions.

It should always be used under specialist supervision for safe and effective long-term management.

Products Reviews

Average Rating
0

5 star
4 star
3 star
2 star
1 star

(Based On 0 reviews Rating)

Write Review

What do you think about this product?

    Bad           Good

Safety & Securities